Diabetes care in South Asian and white European patients with type 2 diabetes.
Aspects of diabetes care in South Asian and white European patients with Type 2 diabetes attending a hospital review clinic were explored. Among the clinic population of 1710 patients, 258 (15%) were of South Asian origin. A significantly greater proportion (95% CI for difference in proportions 8-22%) of these patients was treated with oral hypoglycaemic drugs than in white Europeans, in whom there was a correspondingly greater proportion receiving insulin treatment. In a case-control study, where 154 patients in each racial group were stratified according to treatment regimen, significantly more South Asian patients (13/30 vs 6/30, p < 0.05) on insulin were treated with a once-daily regimen. Despite these observed differences in treatment of diabetes, glycaemic control was no worse in South Asian patients when compared to their white European counterparts. South Asian diabetic patients attending hospital diabetes clinics in the UK can experience similar levels of glycaemic control to white Europeans.
Close
C F
CF
Diabetic Clinic, General Hospital, Birmingham, UK.
Lewis
P G
PG
Holder
R
R
Wright
A D
AD
Nattrass
M
M
D001208:Asia / Q000208:ethnology; D015415:Biomarkers / Q000097:blood; D015992:Body Mass Index; D017691:Caribbean Region / Q000208:ethnology; D016022:Case-Control Studies; D003924:Diabetes Mellitus, Type 2 / Q000178:diet therapy / Q000188:drug therapy*; D003927:Diet, Diabetic; D005260:Female; D019270:Fructosamine; D006595:Hexosamines / Q000097:blood; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D044469:Racial Groups; D012727:Sex Characteristics; D006113:United Kingdom; D044465:White People
D015415:Biomarkers; D006595:Hexosamines; D007004:Hypoglycemic Agents; D007328:Insulin; D019270:Fructosamine